CNS SPECTRUMS

CNS SPECTRUMS

CNS SPECTRUMS
影响因子:4.1
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Cambridge University Press
发刊时间:0
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:1092-8529

期刊介绍

CNS Spectrums covers all aspects of the clinical neurosciences, neurotherapeutics, and neuropsychopharmacology, particularly those pertinent to the clinician and clinical investigator. The journal features focused, in-depth reviews, perspectives, and original research articles. New therapeutics of all types in psychiatry, mental health, and neurology are emphasized, especially first in man studies, proof of concept studies, and translational basic neuroscience studies. Subject coverage spans the full spectrum of neuropsychiatry, focusing on those crossing traditional boundaries between neurology and psychiatry.
CNS光谱涵盖临床神经科学、神经治疗学和神经精神药理学的所有方面,特别是与临床医生和临床研究者相关的方面。该杂志的特点是重点突出,深入的评论,观点和原始的研究文章。强调精神病学、心理健康和神经病学中所有类型的新疗法,特别是首先在人的研究、概念验证研究和转化的基础神经科学研究中。主题涵盖了神经精神病学的全方位,重点是那些跨越神经病学和精神病学之间的传统界限。
年发文量 63
国人发稿量 4.5
国人发文占比 0.07%
自引率 -
平均录取率0
平均审稿周期 >12周,或约稿
版面费 US$3255
偏重研究方向 医学-精神病学
期刊官网 http://www.cnsspectrums.com/
投稿链接 https://mc.manuscriptcentral.com/cnsspectr

期刊高被引文献

Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities.
来源期刊:CNS spectrumsDOI:10.1017/S109285291900124X
Neuroinflammation and cognition across psychiatric conditions.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001499
The effect of caloric restriction on working memory in healthy non-obese adults.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001566
Assessment in Work Productivity and the Relationship with Cognitive Symptoms (AtWoRC): primary analysis from a Canadian open-label study of vortioxetine in patients with major depressive disorder (MDD)
来源期刊:CNS SpectrumsDOI:10.1017/S1092852918000913
Reward systems and cognitions in Major Depressive Disorder.
来源期刊:CNS spectrumsDOI:10.1017/s1092852918001335
Cognitive impairment in major depressive disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001207
Cognition, social cognition, and Self-assessment in schizophrenia: prediction of different elements of everyday functional outcomes.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001414
Neuronal underpinnings of cognitive impairment and - improvement in mood disorders.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001062
Compulsivity is measurable across distinct psychiatric symptom domains and is associated with familial risk and reward-related attentional capture
来源期刊:CNS SpectrumsDOI:10.1017/S1092852919001330
The role of dopamine D3 receptors in the mechanism of action of cariprazine.
来源期刊:CNS spectrumsDOI:10.1017/S109285291900083X
A study on the correlates of habit-, reward-, and fear-related motivations in alcohol use disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001554
A different aspect of the unexpected death of Mozart at the age of 35 years.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001736
Emotional distress, brain functioning, and biobehavioral processes in cancer patients: a neuroimaging review and future directions.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001621
Conducting clinical studies targeting cognition in psychiatry: guiding principles and design.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001074
Altered brain functional networks in Internet gaming disorder: independent component and graph theoretical analysis under a probability discounting task.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001505
50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000427
Decriminalizing mental illness: specialized policing responses.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001640
Neurocognition and social cognition training as treatments for violence and aggression in people with severe mental illness.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001214
45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000385
64 Aripiprazole Long-acting Injectable in Schizophrenia. An 18-month Follow-up and Mirror-image Study.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000506
Keeping Up with Clinical Advances: Opioid Use Disorder.
来源期刊:CNS spectrumsDOI:10.1017/S109285291900110X
27 A New Method for Initiating Treatment with the Long-acting Antipsychotic Aripiprazole Lauroxil.
来源期刊:CNS spectrumsDOI:10.1017/S109285291900021X
95 Differential Aspects Between Schizophrenia Treatment Approaches: Oral Antipsychotics vs Aripiprazole Long-Acting Injectable.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000701
49 Combinatorial Pharmacogenomics to Guide Treatment Selection for Major Depressive Disorder: A Large, Blinded, Randomized Controlled Trial.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000415
34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000282
Dopamine antagonist antipsychotics in diverted forensic populations.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000841
Pharmacological treatment of violence in schizophrenia.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001226
92 Effects of Smartphone Coaching Intervention on Dietary Intake for Bariatric Surgery Candidates: A Pilot Randomized Controlled Trial.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000683
47 Sustained Functional Recovery and Symptom Remission After Maintenance Treatment with Aripiprazole Once-Monthly for Patients with Bipolar I Disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000403
87 Efficacy Measures in an Open-label Dose-Optimization of an Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000658
The following abstracts were presented as posters at the 2018 NEI Congress.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000014
81 Bioequivalence of a Manipulation-Resistant Immediate-Release Amphetamine Sulfate Formulation Compared with Reference Standard.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000609
93 Practical Outpatient Pharmacotherapy for Alcohol Use Disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000695
25 Ventriculoperitoneal Shunt as a Meteorologist: Medtronics Shunt Headaches Vaticinating Climatic Perturbation.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000191
Commentary on: drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001682
61 Heroin Dependence as an Enantiopathy to Quetiapine-Induced Restless Leg Syndrome.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000476
80 Misdiagnosis as a Cause of Treatment Failure in Repetitive Transcranial Magnetic Stimulation Therapy (rTMS) for MDD.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000592
6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECTStudy.
来源期刊:CNS spectrumsDOI:10.1017/S109285291900004X
97 My Inner Blizzard: Effect of Weather on Multiple Sclerosis Exacerbation.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000890
Should antipsychotic medications for schizophrenia be given for a lifetime? Replication of a naturalistic, long-term, follow-up study of antipsychotic treatment.
来源期刊:CNS spectrumsDOI:10.1017/S109285291800144X
39 Long-term Safety and Tolerability of Once-Daily Valbenazine in Patients with Tardive Dyskinesia.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000324
Effective use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation disorder without attention deficit disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001020
Risk of Parkinson’s disease among patients with herpes zoster: a nationwide longitudinal study
来源期刊:CNS SpectrumsDOI:10.1017/S1092852919001664
Brain metastasis affecting frontal lobe misdiagnosed as bipolar disorder, without any neuroimaging exam: two case reports with fatal outcomes.
来源期刊:CNS spectrumsDOI:10.1017/S1092852918001669
Principles and practices of risk assessment in mental health jail diversion programs.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001652
Problematic internet use: an exploration of associations between cognition and COMT rs4818, rs4680 haplotypes.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919001019
82 Ice Melts Phantogeusia: Cold Inhibition of Gustatory Hallucinations.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000610
Predictors of functional response and remission with desvenlafaxine 50 mg and 100 mg: a pooled analysis of randomized, placebo-controlled studies in patients with major depressive disorder.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000828
35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000294
40 Pseudo Cranial Nerve I Dysfunction: Subjective Hyposmia and Subjective Hypogeusia but Normosmia and Normogeusia - 3 cases.
来源期刊:CNS spectrumsDOI:10.1017/S1092852919000336

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
49.21%40.88%-2.53%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
CLINICAL NEUROLOGY
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学3区
PSYCHIATRY 精神病学
3区
CLINICAL NEUROLOGY 临床神经病学
4区
2023年12月升级版
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
PSYCHIATRY 精神病学
3区
2022年12月旧的升级版
医学3区
CLINICAL NEUROLOGY 临床神经病学
3区
PSYCHIATRY 精神病学
3区